LINC02117

Across TCGA pan-cancer cohorts, LINC02117 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC02117’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where LINC02117 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02117 is over-expressed in tumor, although a few such as HNSC show the opposite, repressed pattern.

BRCA and HNSC are the cancer types where LINC02117 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02117 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	II,III,IV	+0.028	.005	6	view →
HNSC	Male	II,III,IV	−0.022	.019	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

LINC02117–BRCA

Open the BRCA breakdown →